BACKGROUND: Because sexually transmitted chlamydial infections are common among young women, it is critical that providers screen and manage these infections appropriately.
jority of chlamydial infections in women are asymptomatic and, untreated may cause pelvic inflammatory disease (PID) and its sequelae: ectopic pregnancy, infertility, and chronic pelvic pain. 2, 3 There is solid evidence that routine screening of young sexually active women prevents PID and reduces the prevalence of infection in the community. 4, 5 The U.S. Preventive Services Task Force and the Centers for Disease Control and Prevention recommend that sexually active females aged 25 or younger be routinely screened for Chlamydia. 1, 6 Despite national guidelines, surveys have consistently demonstrated incomplete Chlamydia screening as well as inadequate risk assessment and education. A national survey in 1999 found that less than one-third of primary care providers reported routine screening of nonpregnant females for Chlamydia. 7 Recent national estimates indicate that less than half of young sexually active women are receiving routine Chlamydia screening in managed care. 8 Studies indicate that adolescents and adults are not routinely receiving sexual risk assessments. [9] [10] [11] [12] [13] [14] Although national data confirm the widespread use of appropriate treatment regimens, 15 only about two-thirds of adolescents receive sexually transmitted disease education and counseling. 10, 12 California has had numerous initiatives to improve STD screening and care. In 1998, the California Chlamydia Action Coalition initiated a multilevel campaign to develop policy and structural interventions to decrease Chlamydia infections in California. Several of these activities, including updated and expanded clinical guidelines and provider education incentives, were targeted to primary care providers, with an emphasis in managed care organizations. 16 California's Family
Planning Access Care Treatment (Family PACT) Program established reimbursement mechanisms to ensure appropriate diagnostic testing (including urine-based technology) and treatment of sexually transmitted diseases for women 200% or below the federal poverty level. 17, 18 With scientific evidence for clinical and public health benefits of Chlamydia screening and clear consistent clinical guidelines, it is important to assess the knowledge, attitudes, and practices of health care providers that care for the population with the highest rate of chlamydial infection: young sexually active women. This survey focused on the Chlamydiarelated clinical practices of primary care physicians and nurse practitioners in California in 2002 to identify ongoing policy and training needs.
METHODS

Sampling
A random sample of 2000 California primary care physicians was obtained from the American Medical Association (AMA) Physician Masterfile, which included members and nonmembers of the AMA (Medical Marketing Service Inc, Wood Dale, IL). The sample was stratified equally among five primary care specialties: family practice, general practice, internal medicine, obstetrics and gynecology, and pediatrics. In addition, all 68 adolescent medicine providers registered in the AMA database were included in the sample. All 1,815 primary care nurse practitioner members of the California Coalition of Nurse Practitioners were surveyed. Sample sizes were chosen to provide sufficient power (80%) to detect a 15% difference in Chlamydia screening rates between physician specialties, given an estimated 60% response rate. Eligibility criteria included practicing in California and providing primary health care to sexually active patients under the age of 30 in the past 3 months. Providers were ineligible if less than 10% of their time was spent providing clinical care or they lacked a valid California telephone number or mailing address.
The questionnaire was mailed to the physician and nurse practitioner samples in December 2001 and March 2002, respectively. All providers received a coupon for a free course given by the California STD/HIV Prevention Training Center. Half of physicians were randomized to receive a $5 cash incentive mailed with the questionnaire. Two follow-up mailings were sent to physician nonrespondents in February and May 2002 and to nurse practitioner nonrespondents in May and August 2002. Physician nonrespondents were contacted by phone to encourage participation and to confirm fax numbers. In August 2002, all nonrespondent physicians were faxed or sent a fourth mailing. Remaining nonrespondents with available fax numbers were faxed surveys in November 2002.
Data Collection
A self-administered survey about STD practices was developed and pilot tested. Survey topics were chosen based on current guidelines for the screening, diagnosis, and management of chlamydial infections. Data on demographics were collected from the AMA file for physicians and included in the survey for nurse practitioners. Additional practice characteristics included specialty type, primary practice setting, and average number of young female patients (15 to 25 years of age) seen per week.
Survey content was divided into 5 topic areas: (1) sexual history taking, (2) evaluation of a young sexually active patient with signs of symptoms suggestive of urethritis or cervicitis, (3) management of a nonpregnant patient with a positive Chlamydia test, (4) availability of STD testing and prevention resources on site, and (5) Chlamydia screening practices and attitudes. For questions related to the frequency of specific clinical practices, providers were given a 5-point scale (never, sometimes, half of the time, usually, always). For questions related to attitudes, providers were given a series of statements and asked to respond on a 5-point scale (strongly disagree, disagree, neutral, agree, strongly agree).
Sexual history taking was assessed in three clinical situations: a routine new patient visit, a routine well care or annual visit, and an acute care visit for any reason other than STDs. Providers were asked, ''How often do you take a sexual history from a young adult (15 to 25 years of age) in each of the following situations?'' Specific topics that were generally included in the sexual history were assessed. Chlamydia screening practices were assessed by the following question, ''When you provide care for sexually active females at an annual wellcare visit without signs or symptoms of an STD in the following age groups, how often do you test for Chlamydia?'' Possible responses were given for each of 3 age groups, less than 20, 20 to 25, and 26 to 34 years. Additionally, providers were asked under what circumstances they test asymptomatic women over the age of 25.
Data Analysis
Routine practice was defined as a response of ''usually'' or ''always'' to a particular clinical practice question. These variables were dichotomized (never/sometimes/half vs usually/ always) for statistical comparison. Similarly, responses to attitude statements were dichotomized (strongly disagree/disagree/neutral vs agree/strongly agree) for statistical comparison. The data were analyzed using SAS and STATA statistical software. 19, 20 Because there was no significant difference in demographics or practice patterns between physicians who received the financial incentive and those who did not, physician samples were combined for final analysis. To generate population estimates, weights were constructed based on the inverse of the sampling fraction of each medical specialty in the AMA database. With the exception of the description of the sample, all analyses used weighted estimates. Because of differences in sampling strategy, comparisons between physician and nurse practitioner samples were not subjected to statistical testing. For 2 Â 2 cross-tabulation, Yates corrected w 2 statistic was used. For crosstabulations with greater than 2 categories of variables, statistical associations were determined using the Pearson w 2 statistic. Statistical significance was defined as
Po.05. Odds ratio estimates and 95% confidence intervals were used to summarize bivariate associations. Multivariate logistic regression was used to determine independent predictors of routine Chlamydia screening of women aged 25 or younger among physicians and nurse practitioners. The outcome variable for the models combined the providers' responses to screening frequency for women under age 20 and 20 to 25 years. A multivariate model was constructed to predict providers that could be targeted for interventions and education. In construction of the model, all demographic variables were tested for significant association with routine screening. Those that were significantly associated with screening at Po.05 in the univariate analysis, were included in the model, with the exception of years since completing residency, which was found to be collinear with age. Other tests for collinearity of independent variables in both the physician and nurse models were run and no significant collinearity between these variables was noted. All 2-way interaction terms were tested. While there was suggestion of an interaction between physician specialty and practice setting in multivariate analysis and stratified tables, the model that included this term was unstable because of cells with zero observations.
RESULTS
Of the 2,068 physicians sampled, 1,456 were determined to be eligible for the study and 708 completed the survey (response rate of 49%). Adolescent medicine specialists were more likely to complete the survey compared with other specialties (82% vs 47%, Po.001). Internal medicine and general practice pro-viders had the lowest response rate (42%). There were no significant differences between the demographic characteristics of respondent and nonrespondent physicians. Of the 1,815 nurse practitioners surveyed, 1,418 were determined eligible and 895 (63%) completed the survey. Demographic data for nonrespondent nurse practitioners were unavailable for comparison to respondents. Selected characteristics of the study groups are presented in Table 1 .
Sexual Risk Assessment
Providers were more likely to report taking a sexual history from young adults (15 to 25 years old) at routine annual or new patient visits compared with acute care, non-STD related visits ( Table 2 ). The proportions of physicians who reported taking a sexual history at routine annual visits varied significantly by specialty: adolescent medicine providers (95%), obstetriciangynecologists (85%), pediatricians (85%), family practitioners (69%), internists (67%), and general practitioners (66%) (Po.001). Over 80% of physicians and nurse practitioners reported routinely asking about the following topics in their sexual risk assessments: the use of condoms or other barrier methods, the use of or need for contraception, and recent sexual activity. Over half (55% of physicians and 72% of nurse practitioners) reported asking about number of sex partners. Slightly fewer (55% of physicians and 62% of nurse practitioners) reported asking about gender of sex partners. In addition, only 30% of physicians and 37% of nurse practitioners reported routinely asking about patient sexual practices (i.e., oral, vaginal, anal intercourse).
Chlamydia Screening
Nearly half of physicians and the majority of nurse practitioners reported routinely screening women age 25 or younger (Table 2) . Among physicians, factors independently associated with routinely screening women age 25 or younger included adolescent medicine specialty (compared with internal medicine), female gender, practicing at either a public, a freestanding Health Maintenance Organization (HMO) or ''other'' setting (compared with private setting), and higher volume of female patients (compared with lowest volume of female patients) (Table 3). Among nurse practitioners, independent predictors of routine Chlamydia screening included practicing in a public, HMO, or ''other'' setting, younger age, and higher patient volume (Table 4) .
Although not currently recommended, reported routine screening of asymptomatic women over the age of 25 was common ( Table 2 ). The most frequently reported reasons for screening older women included the patient's request for a STD check-up (physicians 80% and nurse practitioners 93%), multiple sex partners (physicians 66% and nurse practitioners 83%), previous STD (physicians 56% and nurse practitioners 62%), or indication that partner may have other partners (physicians 56% and nurse practitioners 75%). In addition, the majority of nurse practitioners reported screening older women if they were not using barrier methods consistently (71%) or if they were starting a new relationship (61%).
A common concern among both physicians and nurse practitioners was that Chlamydia tests would not be paid for (Table 2) . Agreement with statements regarding lack of reim- bursement or low prevalence of Chlamydia was significantly associated with lower reported Chlamydia screening rates.
Chlamydia Management Practices and Clinic Services
Presented with a scenario of a nonpregnant patient with a positive Chlamydia test, the majority of providers reported routinely treating patients, providing risk-reduction counseling, advising patients to inform partners, and reporting the case to the health department (Table 5 ). Patient delivered partner therapy for both male and female partners was reportedly provided by nearly half of both physicians and nurse practitioners.
While almost half of providers reported routinely ordering a test of cure for Chlamydia, a small proportion reported testing for reinfection. On site availability of Chlamydia related services such as urine-based Chlamydia testing and single-dose azithromycin was not commonly reported (Table 5) .
DISCUSSION
This survey of primary care physicians and nurse practitioners in California indicated that, although a substantial proportion of providers report appropriate Chlamydia care practices, many others report practices inconsistent with current screening and management guidelines. A compelling finding is the lack of appropriate screening among providers: too few physicians are routinely screening women age 25 and younger and too many nurse practitioners are routinely screening women over 25. Our survey findings provide direction for future interventions to increase appropriate Chlamydia screening, improve sexual risk assessment, and enhance patient follow-up, Despite current recommendations to screen all sexually active women age 25 and younger for chlamydial infection, the rates of reported routine screening were disappointing, especially among physicians. The rate in California appears higher than some national physician estimates, 7 but lower than the self-reported screening rate found among primary care physician and nurse practitioners in Colorado. 23 Independent predictors of screening practices identified in this study will be helpful in targeting outreach and education to primary care providers to improve screening rates. For example, internists, family practitioners, general practitioners, and nurse practitioners in private practice settings may benefit from continuing professional education. Provider outreach could address the misperceptions and barriers to screening, including perceptions that Chlamydia prevalence is too low to warrant screening. Prevalence monitoring in California has consistently found high rates of infection among young women even in private and managed care practice settings. 24 Increasing the availability of urine-based testing may improve screening rates, as it allows providers to screen women for Chlamydia without performing a pelvic exam. Policies to ensure adequate reimbursement for Chlamydia testing as well as risk assessment and risk-reduction counseling are essential for supporting high quality STD care and clinical practice guidelines. A high proportion of providers, particularly nurse practitioners, report routinely screening women over age 25 for Chlamydia. Current guidelines recommend screening these women only if they have risk factors such as multiple partners. 1, 6 Unnecessary screening in low prevalence populations is not cost-efficient and, because the positive predictive value is lower, may lead to an increased proportion of false positive test results. 25 Educating both providers and women about prevalence and risk factors for Chlamydia may decrease unnecessary screening. Deficiencies in repeat testing also were identified. Because the standard treatment efficacy is over 95%, a test of cure for nonpregnant patients treated with a first-line medication is not recommended. Regardless, 40% of providers reported routinely ordering a test of cure. Because of high rates of repeat chlamydial infections and increased risk of reproductive health complications with multiple infections, repeat testing in 2 to 6 months is recommended. 1, 26, 27 Unfortunately, less than one quarter of providers reported retesting women in 2 to 6 months after Chlamydia treatment. The cost efficiency of Chlamydia management can be improved by developing innovative ways to conduct retesting and educating providers to follow clinical guidelines for test of cure and re-testing. There are several limitations to this study. Although a physician response rate of less than two thirds is not uncommon, results may be less representative of primary care physicians. It is noteworthy that demographics of nonresponding physicians were similar to respondents. Using a professional society membership to identify nurse practitioner participants limits the generalizability of our results to all nurse practitioners in California. It is possible that members of this organization are more proactive and reflect higher practice standards than nonmembers. In addition, this study relies on provider self-report, which may not reflect true practice. Because of social desirability and awareness of appropriate practice, selfreport may overestimate quality clinical practice.
Chlamydia remains a significant public health problem, infecting epidemic numbers of young sexually active women. Despite concerted attempts at Chlamydia control, rates in California and throughout the United States remain high. Although this complex problem demands intervention at many levels, a critical part of the solution is widespread, high quality STD/HIV preventive services. This study makes a significant contribution to this effort by identifying gaps in risk assessment, Chlamydia screening, and management practices of primary care providers as well as inadequacies in available onsite services and structural and attitudinal barriers to routine screening. In addition to targeted provider education, interventions that increase reimbursement for prevention, testing, and treatment services may well improve the quality of STD care for young women.
